Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | MMP1 | P03956 | 3/20 | 0.34 |
| ▸ | MMP2 | P08253 | 3/20 | 0.34 |
| ▸ | MMP9 | P14780 | 3/20 | 0.34 |
| ▸ | MMP8 | P22894 | 3/20 | 0.34 |
| ▸ | MMP13 | P45452 | 3/20 | 0.34 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CHAT | P28329 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27267455 | 0.98 | MYC (0.42) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL7706296 | 0.98 | MYC (0.42) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL845825 | 0.95 | TSHR (0.44) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL31021957 | 0.95 | TSHR (0.44) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL28581245 | 0.93 | MYC (0.42) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| Biphenyl SCHEMBL27380486 | 0.87 | TSHR (0.43) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| Acetonitrile SCHEMBL17594987 | 0.84 | MYC (0.41) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL6678754 | 0.80 | TSHR (0.52) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL2972939 | 0.80 | TSHR (0.52) | MYCTSHRSMN1; SMN2TTRFABP4 | |
| SCHEMBL2593808 | 0.78 | PGAM1 (0.40) | MYCTSHRSMN1; SMN2TTRFABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615645-B2 | Method for the continuous production of aldehydes | BASF AKTIENGESELLSCHAFT (DE) | 2009-11-10 | — | — | US | disclosed |
| US-20070004939-A1 | Method for the continuous production of aldehydes | VOLLAND MARTIN | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004939-A1 | Method for the continuous production of aldehydes | HRH4, HRH2, HRH3 | MYC 1206/4885TSHR 3054/4885SMN1; SMN2 3216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.